Evidence map›Paper›PMID 35688593›Full record

ArticleBMJ open2022

Acceptance commitment therapy (ACT) for psychological distress associated with inflammatory bowel disease (IBD): protocol for a feasibility trial of the ACTforIBD programme.

Subhadra Evans, Lisa Olive, Madeleine Dober, Simon Knowles, Matthew Fuller-Tyszkiewicz, Eric O, Peter Gibson, Leanne Raven, Richard Gearry, Andrew McCombie and 4 more

Open access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Psychological interventions for treatment of inflammatory bowel disease.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Subhadra EvansPsychology, Deakin University Faculty of Health, Burwood, Victoria, Australia subhadra.evans@deakin.edu.au.ORCID 0000-0002-1898-0030
Lisa OliveSchool of Pyschology, Deakin, Geelong, Victoria, Australia.
Madeleine DoberSchool of Psychology, Deakin University, Burwood, Victoria, Australia.
Simon KnowlesSchool of Health Sciences, Swinburne University of Technology, Hawthorn, Victoria, Australia.
Matthew Fuller-TyszkiewiczSchool of Psychology, Deakin University, Burwood, Victoria, Australia.
Eric OFaculty of Health, Deakin University, Burwood, Victoria, Australia.
Peter GibsonGastroenterology, Monash University Faculty of Medicine Nursing and Health Sciences, Clayton, Victoria, Australia.
Leanne RavenCrohn's and Colitis Australia, Camberwell, Victoria, Australia.
Richard GearryDepartment of Medicine, Christchurch School of Medicine and Health Sciences, Medicine, Christchurch, New Zealand.
Andrew McCombieMedicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Leesa van NiekerkSchool of Psychological Sciences, University of Tasmania, Hobart, Tasmania, Australia.
Susan ChestermanSchool of Pyschology, Deakin, Geelong, Victoria, Australia.
Daniel RomanoSchool of Pyschology, Deakin, Geelong, Victoria, Australia.
Antonina Mikocka-WalusPsychology, Deakin University Faculty of Health, Burwood, Victoria, Australia.ORCID 0000-0003-4864-3956
Deakin University · AUChristchurch Clinical Studies Trust · NZCrohn's & Colitis Australia · AUMonash University · AUSwinburne University of Technology · AUUniversity of Otago · NZUniversity of Tasmania · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInflammatory bowel disease (IBD) involves an abnormal immune response to healthy gut bacteria. When a person develops IBD, their susceptibility to anxiety and/or depression increases. The ACTforIBD programme, specifically designed for people with IBD and comorbid psychological distress, draws on acceptance and commitment therapy (ACT), which promotes acceptance of situations that cannot be solved such as persistent physical symptoms. There are no ACT trials for IBD using an active control group or a telemedicine approach, which is important to improve accessibility, particularly in the context of the ongoing COVID-19 pandemic. The ACTforIBD programme is administered online with a 4-hour therapist involvement per participant only; if successful it can be widely implemented to improve the well-being of many individuals with IBD. METHODS AND ANALYSIS: Our team have codesigned with consumers the ACTforIBD programme, an 8-week intervention of 1-hour sessions, with the first three sessions and the last session delivered one-to-one by a psychologist, and the other sessions self-directed online. This study aims to evaluate the feasibility and preliminary efficacy of ACTforIBD to reduce psychological distress in patients with IBD. Using a randomised controlled trial, 25 participants will be randomised to ACTforIBD, and 25 patients to an active control condition. ETHICS AND DISSEMINATION: This protocol has been approved by Deakin University Research Ethics Committee in September 2021 (Ref. 2021-263) and the New Zealand Central Health and Disability Ethics Committee in December 2021 (Ref. 2021 EXP 11384). The results of this research will be published in peer-reviewed journals and shared with various stakeholders, including community members, policy-makers and researchers, through local and international conferences. TRIAL REGISTRATION NUMBER: ACTRN12621001316897.

Indexed as

Acceptance and Commitment TherapyInflammatory Bowel DiseasesPsychological DistressChronic DiseaseCOVID-19Feasibility StudiesHumansPandemicsQuality of LifeRandomized Controlled Trials as TopicAdult gastroenterologyInflammatory bowel diseasePSYCHIATRY

Identifiers

PMID35688593
PMCPMC9189839
OpenAlexW4281789401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.